RSK2 protects human breast cancer cells under endoplasmic reticulum stress through activating AMPKα2-mediated autophagy

Lan-Ya Li,Xi-Sha Chen,Kuan-Song Wang,Yi-Di Guan,Xing-Cong Ren,Dong-Sheng Cao,Xin-Yuan Sun,Ao-Xue Li,Yong-Guang Tao,Yi Zhang,Ming-Zhu Yin,Xin-Luan Wang,Ming-Hua Wu,Jin-Ming Yang,Yan Cheng
DOI: https://doi.org/10.1038/s41388-020-01447-0
IF: 8.756
2020-09-21
Oncogene
Abstract:Autophagy can protect stressed cancer cell by degradation of damaged proteins and organelles. However, the regulatory mechanisms behind this cellular process remain incompletely understood. Here, we demonstrate that RSK2 (p90 ribosomal S6 kinase 2) plays a critical role in ER stress-induced autophagy in breast cancer cells. We demonstrated that the promotive effect of RSK2 on autophagy resulted from directly binding of AMPKα2 in nucleus and phosphorylating it at Thr172 residue. IRE1α, an ER membrane-associated protein mediating unfolded protein response (UPR), is required for transducing the signal for activation of ERK1/2-RSK2 under ER stress. Suppression of autophagy by knockdown of RSK2 enhanced the sensitivity of breast cancer cells to ER stress both in vitro and in vivo. Furthermore, we demonstrated that inhibition of RSK2-mediated autophagy rendered breast cancer cells more sensitive to paclitaxel, a chemotherapeutic agent that induces ER stress-mediated cell death. This study identifies RSK2 as a novel controller of autophagy in tumor cells and suggests that targeting RSK2 can be exploited as an approach to reinforce the efficacy of ER stress-inducing agents against cancer.
oncology,genetics & heredity,biochemistry & molecular biology,cell biology
What problem does this paper attempt to address?
This paper aims to explore the role and mechanism of RSK2 in the autophagy process induced by endoplasmic reticulum stress (ER stress) in breast cancer cells. Specifically, the study found that RSK2 protects breast cancer cells from apoptosis caused by endoplasmic reticulum stress by activating AMPK α2 - mediated autophagy. The main research questions of the paper can be summarized as follows: 1. **The role of RSK2 in endoplasmic reticulum stress**: - The researchers found that under endoplasmic reticulum stress conditions, the phosphorylation level of RSK2 increased significantly, indicating that RSK2 may play an important role in endoplasmic reticulum stress. 2. **The interaction between RSK2 and AMPK α2**: - Further research showed that RSK2 can bind to AMPK α2 and phosphorylate AMPK α2 at the Thr172 site, thereby activating the AMPK α2 - mediated autophagy process. 3. **The influence of RSK2 on autophagy**: - By knocking down RSK2, the researchers observed a decrease in the level of the autophagy marker LC3 - II and an increase in the level of the autophagy - inhibiting marker p62, indicating that RSK2 plays a crucial role in the autophagy process induced by endoplasmic reticulum stress. 4. **The role of RSK2 in cell survival and apoptosis**: - Inhibiting the expression of RSK2 enhanced the sensitivity of breast cancer cells to endoplasmic reticulum stress, manifested as a decrease in cell survival rate and an increase in apoptosis. In addition, knocking down RSK2 also increased the cytotoxicity of paclitaxel (a chemotherapeutic drug that induces endoplasmic reticulum stress) to breast cancer cells. 5. **Upstream regulation of the RSK2 signaling pathway**: - The study found that endoplasmic reticulum stress activates RSK2 through the IRE1 α - ERK1/2 signaling pathway. Inhibiting IRE1 α or ERK1/2 can block the activation of RSK2, thereby affecting the autophagy process. In summary, the problem that this paper attempts to solve is: **How does RSK2 protect breast cancer cells by activating AMPK α2 - mediated autophagy under endoplasmic reticulum stress conditions, and explore the potential application of this mechanism in cancer treatment?**